Dow Dull Except for...
Health Care: Drugs
MAP Pharmaceuticals Inc. (MAPP: NASDAQ)
$24.98 -0.02 | -0.08%
03/01/13 - 04:00 PM ET
738.28K / 1.41M
Vol / Avg. Vol:25.00 / 25.00
Open / Prev. Close:24.98 - 25.01
Today's Range:11.11 - 25.03
52 Wk Range:59.62%
Performance YTD:TheStreet Rating:
Portfolios with MAPP
- Portfolio NameUser Type
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- Userrpbatb Portfolio 1
- UserHot Biotech Stocks II
- UserCrankyTrader Random Selection
- UserSMS Portfolio
- UserEd Mahaffey Portfolio - Ble...
- UserWhat would Jesus buy?
- ContributorStockerblog.com Asthma Stocks
- UserInsider Biotech Buys
Latest MAPP Headlines from TheStreet
- Allergan's Healthy Prospects 02.08.13 | 06:02 am
- Cramer's 6 Stocks in 60 Seconds: SNV TXN UL CREE MAPP KBH (Update 1) 01.23.13 | 05:01 pm
- 2013 FDA Drug Approval Decision Calendar 12.19.12 | 09:12 am
- Biotech Stock Mailbag: Aveo, Anthera, Amarin, MAP Pharma 11.20.12 | 10:11 am
- MAP Pharma's Awkward FDA Silence 11.14.12 | 09:11 am
- MAP Pharmaceuticals Inc. Stock Downgraded (MAPP) 04.13.12 | 06:04 am
- MAP Pharmaceuticals Inc. Stock Downgraded (MAPP) 04.02.12 | 04:04 am
- Biotech Stock Mailbag: MAP Pharma, Affymax 03.30.12 | 05:03 am
- Signs Point to MAP Pharma Drug Rejection 03.26.12 | 04:03 pm
- MAP Pharmaceuticals Inc. Stock Upgraded (MAPP) 03.26.12 | 06:03 am
Press Releases for MAPP
- Allergan, Inc. Announces Expiration Of Tender Offer For All Outstanding Shares Of MAP Pharmaceuticals, Inc. And Intent To Exercise Top-Up Option To Effect A Short-Form Merger - Business Wire 03.01.13 | 09:03 am
- Allergan, Inc. And MAP Pharmaceuticals, Inc. Announce The Federal Trade Commission Has Granted Early Termination Of Waiting Period Under Hart-Scott-Rodino Act - Business Wire 02.07.13 | 09:02 am
- Allergan Commences Cash Tender Offer For All Outstanding Shares Of MAP Pharmaceuticals - Business Wire 01.31.13 | 09:01 am
- Faruqi & Faruqi, LLP Is Seeking More Cash For The Shareholders Of MAP Pharmaceuticals, Inc. (MAPP) - Business Wire 01.30.13 | 11:01 am
- Morgan & Morgan Announces Investigation Of MAP Pharmaceuticals (NASDAQ: MAPP) - PR Newswire 01.30.13 | 10:01 am
- Law Office Of Brodsky & Smith, LLC Announces Investigation Of MAP Pharmaceuticals, Inc. - Business Wire 01.26.13 | 12:01 pm
- The Law Firm Of Levi & Korsinsky, LLP Notifies Investors Of Claims Of Breaches Of Fiduciary Duty By The Board Of MAP Pharmaceuticals Inc. In Connection With The Sale Of The Company To Allergan Inc. - PR Newswire 01.25.13 | 03:01 pm
- Harwood Feffer LLP Announces Investigation Of MAP Pharmaceuticals, Inc. - PR Newswire 01.24.13 | 11:01 am
- Rigrodsky & Long, P.A. Announces Investigation Of MAP Pharmaceuticals, Inc. Buyout - Business Wire 01.24.13 | 07:01 am
- The Law Firm Of Levi & Korsinsky, LLP Notifies Investors Of Claims Of Breaches Of Fiduciary Duty By The Board Of MAP Pharmaceuticals Inc. In Connection With The Sale Of The Company To Allergan Inc. - Business Wire 01.24.13 | 07:01 am
Partner Headlines for MAPP
- Why I Sold Allergan - Seeking Alpha 02.01.13 | 07:02 pm
- Company News for November 26, 2012 - Corporate Summary - Zacks 11.26.12 | 10:11 am
- Buy MAP Pharmaceutical For 70% Upside - Seeking Alpha 11.26.12 | 09:11 am
- Morning Market Movers - Benzinga 11.23.12 | 09:11 am
- Wedbush Securities Reiterates Outperform Rating on MAP Pharmaceuticals - Benzinga 11.23.12 | 09:11 am
- 7 High-Growth Small-Cap Stocks With Strong Buy Ratings - Seeking Alpha 07.28.12 | 09:07 am
- Autodesk RESURGENCE and 2 Analyst Notes from Wall Street - Wall St. Cheat Sheet 07.13.12 | 03:07 am
- Map Pharmaceuticals: The Levadex Levitation - Seeking Alpha 04.03.12 | 08:04 am
- MAP Pharma: Making Money From Migraines - Seeking Alpha 03.11.12 | 09:03 am
- 16 Healthcare Stocks Deeply Discounted From Target Price - Seeking Alpha 01.12.12 | 09:01 am
